A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2011
08/25/2011	WO2011059609A3 Dendrimer compositions and methods of synthesis
08/25/2011	WO2011057780A3 Process for preparing ruthenium(0)-olefin complexes
08/25/2011	WO2011055215A3 Novel benzopyran kinase modulators
08/25/2011	WO2011050302A3 Methods and nutritional formulations to increase the efficacy and reduce the side effects of cancer treatment
08/25/2011	WO2011048553A3 Pharmaceutical compositions of pde-5 inhibitors and dapoxetine
08/25/2011	WO2011047384A9 Methods of inhibiting ire1
08/25/2011	WO2011046964A3 Inhibitors of bruton's tyrosine kinase
08/25/2011	WO2011046599A9 Treatment and prognosis with thalidomide in multiple myeloma based on karyotyping and gene expression profiling
08/25/2011	WO2011044587A3 Cytoprotective or therapeutic plant composition
08/25/2011	WO2011041718A3 Treatment of male-pattern baldness by local induction of the metabolic defect of fabry disease
08/25/2011	WO2011041461A3 Polycyclic compounds as lysophosphatidic acid receptor antagonists
08/25/2011	WO2011041385A3 Use of protein kinase c delta (pkcd) inhibitors to treat diabetes, obesity, and hepatic steatosis
08/25/2011	WO2011039338A3 Use of compounds with sglt-1/sglt-2 inhibitor activity for producing medicaments for treatment of bone diseases
08/25/2011	WO2011031890A3 Cancer stem cell-targeted and drug resistant cancer therapy
08/25/2011	WO2011026912A3 Retinoic acid receptor antagonists, mir-10a inhibitors and inhibitors of hoxb1 or hoxb3 repressors for treating pancreatic cancer
08/25/2011	WO2011013987A3 2,2-disubstituted-2h-chromene compound
08/25/2011	WO2011013912A3 Pharmaceutical composition for enhancing radiation therapy for cancer, and method for screening active material for enhancing radiation therapy for cancer
08/25/2011	WO2011011522A3 Potent small molecule inhibitors of autophagy, and methods of use thereof
08/25/2011	WO2011004282A3 Novel polymorphic form of teriflunomide salts
08/25/2011	WO2010150211A3 Use of derivatives of indoles for the treatment of cancer
08/25/2011	WO2010149688A3 Antitumoral compounds
08/25/2011	WO2010147434A3 Use of toosendanin or melia azedarach extracts for preventing or treating dementia
08/25/2011	WO2010132757A9 Antibacterial aminoglycoside analogs
08/25/2011	US20110209248 Novel sugar transporters
08/25/2011	US20110209228 Method of treatment using antimicrobial composition
08/25/2011	US20110209227 Methods for the diagnosis and treatment of bone disorders
08/25/2011	US20110208168 Particle formulations for use in pharmaceutical compositions
08/25/2011	US20110208159 Catheter Locking Composition
08/25/2011	US20110208120 System with a reservoir for perfusion management
08/25/2011	US20110208118 Compositions and means for treating uterine leiomyomata, leiomyoma, myoma, uterine fibroids, endometriosis, adenomyosis and related disorders by mifepristone
08/25/2011	US20110208020 System with a reservoir for perfusion management
08/25/2011	US20110207951 7-Iodo Tetracyclines and Related Methods
08/25/2011	US20110207933 Process for the preparation of ziprasidone
08/25/2011	US20110207831 Ready-to-use, stable emulsion
08/25/2011	US20110207830 Composition for treating or preventing amyloid-related diseases comprising 4-o-methylhonokiol
08/25/2011	US20110207828 Methods for the prevention and treatment of cerebral ischemia
08/25/2011	US20110207827 Method for determining sensitivity or resistance to compounds that activate the brain serotonin system
08/25/2011	US20110207826 Lactose and cellulose-based tableting aid
08/25/2011	US20110207825 Methods for Concomitant Administration of Colchicine and Macrolide Antibiotics
08/25/2011	US20110207824 Formulation of an injectable paracetamol solution, method for preparing and packaging such a solution and device for packaging such a solution
08/25/2011	US20110207823 12-hour sustained-release metoclopramide
08/25/2011	US20110207821 Method of lowering circulating oxidized low density lipoprotein-beta-2-glycoprotein 1 complex for treatment of atherosclerosis
08/25/2011	US20110207820 Novel chrysochromulina species, methods and media therefor, and products derived therefrom
08/25/2011	US20110207819 Fat Emulsion for Artificially Feeding Seriously Ill Intensive Care Patients
08/25/2011	US20110207817 Anti-inflammatory compounds and compositions thereof
08/25/2011	US20110207816 Alternate morpheeins of allosteric proteins as a target for the development of bioactive molecules
08/25/2011	US20110207815 Tetrahydronaphthalene compounds
08/25/2011	US20110207814 Combination Therapy for Breast Cancer Treatment
08/25/2011	US20110207813 Pharmaceutical composition with gelling properties containing a tyrosine derivative
08/25/2011	US20110207812 Substituted arylamino-1,2,3,4-tetrahydro naphthalenes and -2,3-dihydro-1h-indenes as potassium channel modulators
08/25/2011	US20110207811 Use of celivarone for reducing occurrences of cardiovascular hospitalization
08/25/2011	US20110207810 N1-benzo[1,3]dioxol-5-ylmethyl-n2-substituted biguanide derivative, preparation method thereof, and pharmaceutical composition containing same
08/25/2011	US20110207809 Method of accelerating corneal wound healing
08/25/2011	US20110207808 Long-chain carboxychromanols and analogs for use as anti-inflammatory agents
08/25/2011	US20110207807 New use for homoisoflavone or a salt thereof
08/25/2011	US20110207806 Formulation of dual cycloxygenase (cox) and lipoxygenase (lox) inhibitors for mammal skin care
08/25/2011	US20110207805 Composition of flavanolignan and amino acid with improved water solubility
08/25/2011	US20110207804 Compositions for the treatment of neoplastic diseases
08/25/2011	US20110207803 Taxane Pro-Emulsion Formulations and Methods Making and Using the Same
08/25/2011	US20110207802 Glutamic acid decarboxylase (gad) based delivery system
08/25/2011	US20110207801 Novel Genes, Compositions, and Methods for Modulating the Unfolded Protein Response
08/25/2011	US20110207800 HIV-Dependent expression constructs and uses therefore
08/25/2011	US20110207799 Compositions for Targeted Delivery of siRNA
08/25/2011	US20110207798 Method for treating breast cancer using adenine nucleotide translocator 2 (ant2) sirna or ant2 shrna
08/25/2011	US20110207797 Enhanced antisense oligonucleotides
08/25/2011	US20110207796 Alpha-synuclein kinase
08/25/2011	US20110207795 Smad7 inhibitor compositions and uses thereof
08/25/2011	US20110207794 Pharmaceutical composition
08/25/2011	US20110207793 1-aminocyclohexane derivatives for the treatment of sleep disorders.
08/25/2011	US20110207791 Composition of a 5-ht2a serotonin receptor modulator useful for the treatment of disorders related thereto
08/25/2011	US20110207790 Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea and crystalline forms related thereto
08/25/2011	US20110207789 Methods related to casein kinase ii (ck2) inhibitors and the use of purinosome-disrupting ck2 inhibitors for anti-cancer therapy agents
08/25/2011	US20110207788 5-Ring Heteroaromatic compounds and their use as binding partners for 5-ht5 receptors
08/25/2011	US20110207787 Antimicrobial compositions
08/25/2011	US20110207785 2-Aryl-Propionic Acids and Derivatives and Pharmaceutical Compositions Containing Them
08/25/2011	US20110207784 Oxadiazole-2-oxides as antischistosomal agents
08/25/2011	US20110207783 Renin inhibitors
08/25/2011	US20110207782 Nicotine-containing product
08/25/2011	US20110207780 Therapeutic Salt Compositions and Methods
08/25/2011	US20110207779 Process for the preparation of esomeprazole magnesium
08/25/2011	US20110207777 Benzimidazoles which have activity at m1 receptor and their uses in medicine
08/25/2011	US20110207776 Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
08/25/2011	US20110207774 Triazolothiadiazole inhibitor of c-met protein kinase
08/25/2011	US20110207773 Novel phenyl-quinoline-carboxylic acid pyridine derivatives useful as modulators of nicotinic acetylcholine receptors
08/25/2011	US20110207772 Glycine Chroman-6-Sulfonamides for Use as Inhibitors of Diacylglycerol Lipase
08/25/2011	US20110207770 Pharmaceutical product comprising a muscarinic receptor antagonist and a second active ingredient
08/25/2011	US20110207769 Stable crystalline salt of (r)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabicyclo [2.2.2]oct-3-yl ester
08/25/2011	US20110207768 Pharmaceutical combination of antibacterial and antifungal cream
08/25/2011	US20110207767 Novel cc-1065 Analogs and Their Conjugates
08/25/2011	US20110207766 Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts
08/25/2011	US20110207765 Topical composition comprising a combination of at least two penetration enhancing agents
08/25/2011	US20110207764 Cyclopolysaccharide compositions
08/25/2011	US20110207763 8-carboxamido-2,6-methano-3-benzazocines
08/25/2011	US20110207762 Oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone
08/25/2011	US20110207761 Diversion- and/or abuse-resistant aompositions and methods for making the same
08/25/2011	US20110207760 Sn-38 compositions
08/25/2011	US20110207759 Method for treatment of atherosclerotic disease
08/25/2011	US20110207758 Methods for Therapeutic Renal Denervation
08/25/2011	US20110207757 Tricyclic Compounds Having Cytostatic and/or Cytoxic Activity and Methods of Use Thereof
08/25/2011	US20110207756 Antitumor agent for thyroid cancer

1 ... 1590 1591 1592 1593 1594 1595 1596 1597 1598 1599 1600 1601 1602 1603 1604 1605 1606 1607 1608 1609 1610 ... 7860